119 related articles for article (PubMed ID: 29190690)
1. Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.
De Silva NH; Akazawa T; Wijewardana V; Inoue N; Oyamada M; Ohta A; Tachibana Y; Wijesekera DPH; Kuwamura M; Nishizawa Y; Itoh K; Izawa T; Hatoya S; Hasegawa T; Yamate J; Inaba T; Sugiura K
PLoS One; 2017; 12(11):e0188738. PubMed ID: 29190690
[TBL] [Abstract][Full Text] [Related]
2. IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models.
Mito K; Sugiura K; Ueda K; Hori T; Akazawa T; Yamate J; Nakagawa H; Hatoya S; Inaba M; Inoue N; Ikehara S; Inaba T
Cancer Res; 2010 Sep; 70(18):7093-101. PubMed ID: 20823157
[TBL] [Abstract][Full Text] [Related]
3. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
4. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
5. Development of a dendritic cell-targeting lipopeptide as an immunoadjuvant that inhibits tumor growth without inducing local inflammation.
Akazawa T; Ohashi T; Nakajima H; Nishizawa Y; Kodama K; Sugiura K; Inaba T; Inoue N
Int J Cancer; 2014 Dec; 135(12):2847-56. PubMed ID: 24789268
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.
Vo MC; Lee HJ; Kim JS; Hoang MD; Choi NR; Rhee JH; Lakshmanan VK; Shin SJ; Lee JJ
Oncotarget; 2015 Oct; 6(32):33781-90. PubMed ID: 26418952
[TBL] [Abstract][Full Text] [Related]
7. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
[TBL] [Abstract][Full Text] [Related]
11. Species-specific properties and translational aspects of canine dendritic cells.
Qeska V; Baumgärtner W; Beineke A
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):181-92. PubMed ID: 23280245
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with dendritic cells in an animal model of early pulmonary metastatic squamous cell carcinoma.
Moon JH; Chung MK; Son YI
Laryngoscope; 2012 Nov; 122(11):2442-6. PubMed ID: 22926978
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsumura H
Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
15. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal.
Lee H; Park HJ; Sohn HJ; Kim JM; Kim SJ
J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
Wei H; Wang H; Lu B; Li B; Hou S; Qian W; Fan K; Dai J; Zhao J; Guo Y
Cancer Res; 2008 May; 68(10):3854-62. PubMed ID: 18483270
[TBL] [Abstract][Full Text] [Related]
20. Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy.
Boss MK; Watts R; Harrison LG; Hopkins S; Chow L; Trageser E; Easton C; LaRue SM; Regan D; Dewhirst MW; Dow S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
